Carregant...
Exposure and response prevention helps adults with obsessive compulsive disorder who do not respond to pharmacological augmentation strategies
OBJECTIVE: Serotonin reuptake inhibitors (SRIs) are a first-line treatment for obsessive-compulsive disorder (OCD). Yet, most OCD patients on SRIs do not show excellent response, and recent studies show that augmenting SRIs with risperidone benefits a minority of patients. We evaluated the effective...
Guardat en:
| Publicat a: | J Clin Psychiatry |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5135093/ https://ncbi.nlm.nih.gov/pubmed/26613263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.14m09513 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|